Delivery Order SPE2DB24D2100-SPE2DB25FBBQG
Award Date
1/8/25
Potential Completion Date
1/9/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,841.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of INSULIN GLARGINE-YFGN U100 PEN 3ML, a critical pharmaceutical product, with a performance period through December 27, 2024. The contract is structured as a Firm Fixed Price Delivery Order and is not designated with any set-aside requirements, indicating open...
This federal contract award, valued at $2,494.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INSULIN GLARGINE-YFGN U100 PEN 3ML, classified under the federal contract description code 4566947222. The contract has an ultimate completion date of January 16, 2025, and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.09 firm fixed price delivery order is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a critical medication for diabetes management. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $4,091.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Glargine-yfgn U100 Pen 3ML, a critical medication used for the management of diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,091.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of insulin glargine-yfgn U100 pens, a critical diabetes management medication, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $42,359.34 firm fixed-price contract is for the provision of Insulin Glargine-yfgn U100 Pen 3ML. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary contracting vehicle for AmerisourceBergen to supply a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,582.59 firm fixed-price delivery order is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a critical medication for diabetes management. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Glargine-yfgn U100 Pen 3ML, a critical medical commodity, over a period ending on January 21, 2025. The contract has a firm fixed price ceiling value of $9,744.82 and is designated as a delivery order, without any set-aside requirements. AmerisourceBergen holds a significant...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4563977468 - Insulin Glargine-YFGN U100 Pen 3ML to DLA Troop Support Medical. This $4,556.89 delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to...
This is a $17,179.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565372242 Insulin Glargine-yfgn U100 Pen 3ML. The contract has an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...